Ecstasy produces left ventricular dysfunction and oxidative stress in rats

Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductanc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular research 2008-09, Vol.79 (4), p.662-670
Hauptverfasser: Shenouda, Sylvia K., Lord, Kevin C., McIlwain, Elizabeth, Lucchesi, Pamela A., Varner, Kurt J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 670
container_issue 4
container_start_page 662
container_title Cardiovascular research
container_volume 79
creator Shenouda, Sylvia K.
Lord, Kevin C.
McIlwain, Elizabeth
Lucchesi, Pamela A.
Varner, Kurt J.
description Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.
doi_str_mv 10.1093/cvr/cvn129
format Article
fullrecord <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2732062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cvr/cvn129</oup_id><sourcerecordid>10.1093/cvr/cvn129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVoqZ20l_yAoksvgU30uVpdAolx4gRDDmmh-CLGWm2rdrNrJK2x_31kbJzm0sMwM8wz7wwvQueUXFKi-ZVdhxwdZfoEjamSsuBMyA9oTAipipKXfIROY_yTWymV-IRGtBJaloqM0ePUxgRxi1ehrwfrIm5dk_DadSl4O7QQcL2NzdDZ5PsOQ1fjfuNrSH7tcEzBxYh9hwOk-Bl9bKCN7sshn6Efd9Pvk1kxf7p_mNzMCyuUSAWvbVVTsFKDsMppaZfQEHAKiCKNKnVNLJSN1pJRzpSg1JW5ybXklWTAz9D1Xnc1LF9cbXevQmtWwb9A2JoevHk_6fxv86tfG6Y4IyXLAhd7ARv6GINrjruUmJ2jJjtq9o5m-Ou_197Qg4UZ-HYAIFpomwCd9fHIMSK1IKV64_ph9f-DxZ7zMbnNkYTw12QVJc3s58LMRbWYPE-4ueWvWtudhw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Shenouda, Sylvia K. ; Lord, Kevin C. ; McIlwain, Elizabeth ; Lucchesi, Pamela A. ; Varner, Kurt J.</creator><creatorcontrib>Shenouda, Sylvia K. ; Lord, Kevin C. ; McIlwain, Elizabeth ; Lucchesi, Pamela A. ; Varner, Kurt J.</creatorcontrib><description>Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvn129</identifier><identifier>PMID: 18495670</identifier><identifier>CODEN: CVREAU</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Animals ; Biological and medical sciences ; Calcium Signaling - drug effects ; Cardiac myocytes ; Cardiology. Vascular system ; Cells, Cultured ; Diastole ; Dilatation, Pathologic ; Ecstasy ; Electric Stimulation ; Hallucinogens - administration &amp; dosage ; Hallucinogens - toxicity ; Heart ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart Ventricles - drug effects ; Heart Ventricles - metabolism ; Injections, Intravenous ; Kinetics ; Male ; MDMA ; Medical sciences ; Muscle Proteins - metabolism ; Myocardial Contraction - drug effects ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; N-Methyl-3,4-methylenedioxyamphetamine - administration &amp; dosage ; N-Methyl-3,4-methylenedioxyamphetamine - toxicity ; Original ; Oxidative Stress - drug effects ; Pressure–volume loops ; Proteomics ; Rats ; Rats, Sprague-Dawley ; Systole ; Tyrosine - analogs &amp; derivatives ; Tyrosine - metabolism ; Tyrosine nitration ; Ultrasonography ; Ventricular Dysfunction, Left - chemically induced ; Ventricular Dysfunction, Left - diagnostic imaging ; Ventricular Dysfunction, Left - metabolism ; Ventricular Dysfunction, Left - physiopathology</subject><ispartof>Cardiovascular research, 2008-09, Vol.79 (4), p.662-670</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org 2008</rights><rights>2008 INIST-CNRS</rights><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</citedby><cites>FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20594067$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18495670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shenouda, Sylvia K.</creatorcontrib><creatorcontrib>Lord, Kevin C.</creatorcontrib><creatorcontrib>McIlwain, Elizabeth</creatorcontrib><creatorcontrib>Lucchesi, Pamela A.</creatorcontrib><creatorcontrib>Varner, Kurt J.</creatorcontrib><title>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Calcium Signaling - drug effects</subject><subject>Cardiac myocytes</subject><subject>Cardiology. Vascular system</subject><subject>Cells, Cultured</subject><subject>Diastole</subject><subject>Dilatation, Pathologic</subject><subject>Ecstasy</subject><subject>Electric Stimulation</subject><subject>Hallucinogens - administration &amp; dosage</subject><subject>Hallucinogens - toxicity</subject><subject>Heart</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - metabolism</subject><subject>Injections, Intravenous</subject><subject>Kinetics</subject><subject>Male</subject><subject>MDMA</subject><subject>Medical sciences</subject><subject>Muscle Proteins - metabolism</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>N-Methyl-3,4-methylenedioxyamphetamine - administration &amp; dosage</subject><subject>N-Methyl-3,4-methylenedioxyamphetamine - toxicity</subject><subject>Original</subject><subject>Oxidative Stress - drug effects</subject><subject>Pressure–volume loops</subject><subject>Proteomics</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Systole</subject><subject>Tyrosine - analogs &amp; derivatives</subject><subject>Tyrosine - metabolism</subject><subject>Tyrosine nitration</subject><subject>Ultrasonography</subject><subject>Ventricular Dysfunction, Left - chemically induced</subject><subject>Ventricular Dysfunction, Left - diagnostic imaging</subject><subject>Ventricular Dysfunction, Left - metabolism</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rGzEQhkVoqZ20l_yAoksvgU30uVpdAolx4gRDDmmh-CLGWm2rdrNrJK2x_31kbJzm0sMwM8wz7wwvQueUXFKi-ZVdhxwdZfoEjamSsuBMyA9oTAipipKXfIROY_yTWymV-IRGtBJaloqM0ePUxgRxi1ehrwfrIm5dk_DadSl4O7QQcL2NzdDZ5PsOQ1fjfuNrSH7tcEzBxYh9hwOk-Bl9bKCN7sshn6Efd9Pvk1kxf7p_mNzMCyuUSAWvbVVTsFKDsMppaZfQEHAKiCKNKnVNLJSN1pJRzpSg1JW5ybXklWTAz9D1Xnc1LF9cbXevQmtWwb9A2JoevHk_6fxv86tfG6Y4IyXLAhd7ARv6GINrjruUmJ2jJjtq9o5m-Ou_197Qg4UZ-HYAIFpomwCd9fHIMSK1IKV64_ph9f-DxZ7zMbnNkYTw12QVJc3s58LMRbWYPE-4ueWvWtudhw</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Shenouda, Sylvia K.</creator><creator>Lord, Kevin C.</creator><creator>McIlwain, Elizabeth</creator><creator>Lucchesi, Pamela A.</creator><creator>Varner, Kurt J.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20080901</creationdate><title>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</title><author>Shenouda, Sylvia K. ; Lord, Kevin C. ; McIlwain, Elizabeth ; Lucchesi, Pamela A. ; Varner, Kurt J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Calcium Signaling - drug effects</topic><topic>Cardiac myocytes</topic><topic>Cardiology. Vascular system</topic><topic>Cells, Cultured</topic><topic>Diastole</topic><topic>Dilatation, Pathologic</topic><topic>Ecstasy</topic><topic>Electric Stimulation</topic><topic>Hallucinogens - administration &amp; dosage</topic><topic>Hallucinogens - toxicity</topic><topic>Heart</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - metabolism</topic><topic>Injections, Intravenous</topic><topic>Kinetics</topic><topic>Male</topic><topic>MDMA</topic><topic>Medical sciences</topic><topic>Muscle Proteins - metabolism</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>N-Methyl-3,4-methylenedioxyamphetamine - administration &amp; dosage</topic><topic>N-Methyl-3,4-methylenedioxyamphetamine - toxicity</topic><topic>Original</topic><topic>Oxidative Stress - drug effects</topic><topic>Pressure–volume loops</topic><topic>Proteomics</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Systole</topic><topic>Tyrosine - analogs &amp; derivatives</topic><topic>Tyrosine - metabolism</topic><topic>Tyrosine nitration</topic><topic>Ultrasonography</topic><topic>Ventricular Dysfunction, Left - chemically induced</topic><topic>Ventricular Dysfunction, Left - diagnostic imaging</topic><topic>Ventricular Dysfunction, Left - metabolism</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shenouda, Sylvia K.</creatorcontrib><creatorcontrib>Lord, Kevin C.</creatorcontrib><creatorcontrib>McIlwain, Elizabeth</creatorcontrib><creatorcontrib>Lucchesi, Pamela A.</creatorcontrib><creatorcontrib>Varner, Kurt J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shenouda, Sylvia K.</au><au>Lord, Kevin C.</au><au>McIlwain, Elizabeth</au><au>Lucchesi, Pamela A.</au><au>Varner, Kurt J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>79</volume><issue>4</issue><spage>662</spage><epage>670</epage><pages>662-670</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><coden>CVREAU</coden><abstract>Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18495670</pmid><doi>10.1093/cvr/cvn129</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-6363
ispartof Cardiovascular research, 2008-09, Vol.79 (4), p.662-670
issn 0008-6363
1755-3245
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2732062
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Biological and medical sciences
Calcium Signaling - drug effects
Cardiac myocytes
Cardiology. Vascular system
Cells, Cultured
Diastole
Dilatation, Pathologic
Ecstasy
Electric Stimulation
Hallucinogens - administration & dosage
Hallucinogens - toxicity
Heart
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Heart Ventricles - drug effects
Heart Ventricles - metabolism
Injections, Intravenous
Kinetics
Male
MDMA
Medical sciences
Muscle Proteins - metabolism
Myocardial Contraction - drug effects
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
Myocytes, Cardiac - pathology
N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage
N-Methyl-3,4-methylenedioxyamphetamine - toxicity
Original
Oxidative Stress - drug effects
Pressure–volume loops
Proteomics
Rats
Rats, Sprague-Dawley
Systole
Tyrosine - analogs & derivatives
Tyrosine - metabolism
Tyrosine nitration
Ultrasonography
Ventricular Dysfunction, Left - chemically induced
Ventricular Dysfunction, Left - diagnostic imaging
Ventricular Dysfunction, Left - metabolism
Ventricular Dysfunction, Left - physiopathology
title Ecstasy produces left ventricular dysfunction and oxidative stress in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A42%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ecstasy%20produces%20left%20ventricular%20dysfunction%20and%20oxidative%20stress%20in%20rats&rft.jtitle=Cardiovascular%20research&rft.au=Shenouda,%20Sylvia%20K.&rft.date=2008-09-01&rft.volume=79&rft.issue=4&rft.spage=662&rft.epage=670&rft.pages=662-670&rft.issn=0008-6363&rft.eissn=1755-3245&rft.coden=CVREAU&rft_id=info:doi/10.1093/cvr/cvn129&rft_dat=%3Coup_pubme%3E10.1093/cvr/cvn129%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18495670&rft_oup_id=10.1093/cvr/cvn129&rfr_iscdi=true